Cite
Nannini M, Nigro MC, Vincenzi B, et al. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017;9(12):731-739doi: 10.1177/1758834017742627.
Nannini, M., Nigro, M. C., Vincenzi, B., Fumagalli, E., Grignani, G., D'Ambrosio, L., Badalamenti, G., Incorvaia, L., Bracci, R., Gasperoni, S., Saponara, M., Gatto, L., Indio, V., Astolfi, A., Di Scioscio, V., Casali, P. G., Tonini, G., Aglietta, M., Russo, A., Biasco, G., & Pantaleo, M. A. (2017). Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Therapeutic advances in medical oncology, 9(12), 731-739. https://doi.org/10.1177/1758834017742627
Nannini, Margherita, et al. "Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice." Therapeutic advances in medical oncology vol. 9,12 (2017): 731-739. doi: https://doi.org/10.1177/1758834017742627
Nannini M, Nigro MC, Vincenzi B, Fumagalli E, Grignani G, D'Ambrosio L, Badalamenti G, Incorvaia L, Bracci R, Gasperoni S, Saponara M, Gatto L, Indio V, Astolfi A, Di Scioscio V, Casali PG, Tonini G, Aglietta M, Russo A, Biasco G, Pantaleo MA. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017 Dec;9(12):731-739. doi: 10.1177/1758834017742627. Epub 2017 Dec 19. PMID: 29449894; PMCID: PMC5808843.
Copy
Download .nbib